CH642544A5 - Composition pharmaceutique d'erythromycine. - Google Patents
Composition pharmaceutique d'erythromycine. Download PDFInfo
- Publication number
- CH642544A5 CH642544A5 CH938879A CH938879A CH642544A5 CH 642544 A5 CH642544 A5 CH 642544A5 CH 938879 A CH938879 A CH 938879A CH 938879 A CH938879 A CH 938879A CH 642544 A5 CH642544 A5 CH 642544A5
- Authority
- CH
- Switzerland
- Prior art keywords
- erythromycin
- solution
- propylene glycol
- ethanol
- acid
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title claims 39
- 229960003276 erythromycin Drugs 0.000 title claims 19
- 239000008194 pharmaceutical composition Substances 0.000 title claims 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 32
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 24
- 239000000243 solution Substances 0.000 claims 15
- 235000019441 ethanol Nutrition 0.000 claims 11
- 239000002253 acid Substances 0.000 claims 10
- 231100000252 nontoxic Toxicity 0.000 claims 8
- 230000003000 nontoxic effect Effects 0.000 claims 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 7
- 208000002874 Acne Vulgaris Diseases 0.000 claims 5
- 206010000496 acne Diseases 0.000 claims 5
- 238000010790 dilution Methods 0.000 claims 5
- 239000012895 dilution Substances 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 206010033733 Papule Diseases 0.000 claims 3
- 230000003115 biocidal effect Effects 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 239000011521 glass Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- NWXMGUDVXFXRIG-PMXORCKASA-N (4r,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-PMXORCKASA-N 0.000 claims 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N 1-dodecanol group Chemical class C(CCCCCCCCCCC)O LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims 1
- NZJXADCEESMBPW-UHFFFAOYSA-N 1-methylsulfinyldecane Chemical compound CCCCCCCCCCS(C)=O NZJXADCEESMBPW-UHFFFAOYSA-N 0.000 claims 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims 1
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical group COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 claims 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- WPMWEFXCIYCJSA-UHFFFAOYSA-N Tetraethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCO WPMWEFXCIYCJSA-UHFFFAOYSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 claims 1
- 229960005287 lincomycin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 238000003860 storage Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95315978A | 1978-10-20 | 1978-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH642544A5 true CH642544A5 (fr) | 1984-04-30 |
Family
ID=25493654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH938879A CH642544A5 (fr) | 1978-10-20 | 1979-10-18 | Composition pharmaceutique d'erythromycine. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0010437B1 (OSRAM) |
| JP (1) | JPS5557519A (OSRAM) |
| AU (1) | AU529422B2 (OSRAM) |
| BE (1) | BE879471A (OSRAM) |
| CA (1) | CA1129772A (OSRAM) |
| CH (1) | CH642544A5 (OSRAM) |
| DE (1) | DE2967163D1 (OSRAM) |
| FR (1) | FR2439016A1 (OSRAM) |
| GB (1) | GB2031728B (OSRAM) |
| IE (1) | IE49086B1 (OSRAM) |
| LU (1) | LU81799A1 (OSRAM) |
| NZ (1) | NZ191847A (OSRAM) |
| ZA (1) | ZA795492B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59104326A (ja) * | 1982-12-04 | 1984-06-16 | Toyo Jozo Co Ltd | マクロライド抗生物質の安定な経口用製剤および安定化法 |
| EP0257086B1 (en) * | 1986-01-31 | 1993-01-20 | WHITBY RESEARCH, Inc. | Skinpenetration enhancing compositions |
| US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
| FI883337A7 (fi) * | 1987-07-16 | 1989-01-17 | Bristol Myers Squibb Co | Doksorubisiinihydrokloridin ei-vesiliuoksia |
| FI883338A7 (fi) * | 1987-07-16 | 1989-01-17 | Bristol Myers Squibb Co | Doksorubisiinihydrokloridin vesiliuoksia |
| JPH0737389B2 (ja) * | 1989-08-29 | 1995-04-26 | 久光製薬株式会社 | プロスタグランジンｅ１含有の軟膏剤 |
| DE19549794B4 (de) * | 1994-10-26 | 2009-07-30 | Novartis Ag | Pharmazeutische Zusammensetzungen |
| GB2327611B (en) * | 1994-10-26 | 1999-06-02 | Novartis Ag | Macrolide compositions |
| US5723447A (en) * | 1996-07-02 | 1998-03-03 | Rhone Merieux, Inc. | Water miscible erythromycin solutions |
| US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
| RU2161955C1 (ru) * | 1999-07-16 | 2001-01-20 | Эпштейн Олег Ильич | Способ изменения физико-химических или физико-химических и биологических свойств вещества |
| WO2002078669A1 (fr) * | 2001-03-30 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Solutions medicinales |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4000263A (en) * | 1975-05-02 | 1976-12-28 | Westwood Pharmaceuticals, Inc. | Erythromycin solution |
| FR2378523A1 (fr) * | 1977-01-26 | 1978-08-25 | Grupper Charles | Medicament pour le traitement de l'acne |
-
1979
- 1979-10-15 AU AU51790/79A patent/AU529422B2/en not_active Expired
- 1979-10-15 NZ NZ191847A patent/NZ191847A/xx unknown
- 1979-10-15 ZA ZA00795492A patent/ZA795492B/xx unknown
- 1979-10-17 CA CA337,789A patent/CA1129772A/en not_active Expired
- 1979-10-18 BE BE1/9572A patent/BE879471A/fr not_active IP Right Cessation
- 1979-10-18 FR FR7925929A patent/FR2439016A1/fr active Granted
- 1979-10-18 CH CH938879A patent/CH642544A5/fr not_active IP Right Cessation
- 1979-10-18 LU LU81799A patent/LU81799A1/fr unknown
- 1979-10-19 DE DE7979302271T patent/DE2967163D1/de not_active Expired
- 1979-10-19 EP EP79302271A patent/EP0010437B1/en not_active Expired
- 1979-10-19 JP JP13583179A patent/JPS5557519A/ja active Granted
- 1979-10-19 IE IE1995/79A patent/IE49086B1/en not_active IP Right Cessation
- 1979-10-19 GB GB7936426A patent/GB2031728B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE879471A (fr) | 1980-04-18 |
| FR2439016A1 (fr) | 1980-05-16 |
| FR2439016B1 (OSRAM) | 1983-05-27 |
| EP0010437B1 (en) | 1984-08-08 |
| IE49086B1 (en) | 1985-07-24 |
| GB2031728B (en) | 1983-02-16 |
| LU81799A1 (fr) | 1980-01-25 |
| DE2967163D1 (en) | 1984-09-13 |
| EP0010437A2 (en) | 1980-04-30 |
| ZA795492B (en) | 1981-05-27 |
| AU529422B2 (en) | 1983-06-09 |
| CA1129772A (en) | 1982-08-17 |
| JPH0157097B2 (OSRAM) | 1989-12-04 |
| JPS5557519A (en) | 1980-04-28 |
| IE791995L (en) | 1980-04-20 |
| EP0010437A3 (en) | 1981-05-13 |
| AU5179079A (en) | 1980-04-24 |
| NZ191847A (en) | 1982-05-31 |
| GB2031728A (en) | 1980-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6936893B2 (ja) | Ｓｇｌｔ−２阻害剤含む液体医薬組成物 | |
| US5082863A (en) | Pharmaceutical composition of florfenicol | |
| CH642544A5 (fr) | Composition pharmaceutique d'erythromycine. | |
| US8900634B2 (en) | Diethylstilbestrol dosage form and methods of treatment using thereof | |
| OA10678A (fr) | Nouvelles formulations liquides stables à base de paracétamol et leur mode de préparation | |
| EP0221176A1 (en) | PHARMACEUTICAL CARRIERS FOR REDUCING THE TRANSDERMAL FLOW. | |
| US3070499A (en) | Parenteral aqueous solutions of fat soluble vitamins | |
| JPS6321648B2 (OSRAM) | ||
| DE2218147C2 (de) | Pharmazeutische Zubereitung | |
| EP2116241B1 (en) | Pharmaceutical composition | |
| Fang et al. | Hypoglycemic activity and chemical structure of the salicylates | |
| US7014871B1 (en) | Iodine preparation composition | |
| RS50685B (sr) | Koncentrovani vodeni rastvor ambroksola | |
| EP0896819A1 (en) | Antiglucocorticoid drug | |
| US4132777A (en) | Antifungal compositions and method | |
| FR2614203A1 (fr) | Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation. | |
| US4894237A (en) | Antiinflammatory pharmaceutical composition endowed with sustained effect for topical use | |
| JPS609486B2 (ja) | ステロイド組成物 | |
| JPH09176014A (ja) | 抗真菌性外用組成物 | |
| JPS59219218A (ja) | 局所用作用持続組成物 | |
| WO1996033743A1 (fr) | Compositions pulverulentes et solubles dans l'eau et leurs applications | |
| CN106943348B (zh) | 一种乳酸依沙吖啶油膜剂及其制备方法 | |
| Herbai | Effect of Adrenalectomy, Corticosteroids and some other Anti‐Inflammatory Agents, Salazopyrin®, Thyroxine and Vitamin A on the Exchangeable Sulphate Pool and on Sulphate Incorporation in Vivo into Costal Cartilage of the Mouse | |
| US5543432A (en) | Application of trace elements to animals | |
| JPS59101478A (ja) | リグスチライドを安定に配合した水系組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |